Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 7
1982 5
1983 4
1984 4
1985 12
1986 6
1987 3
1988 7
1989 15
1990 9
1991 12
1992 18
1993 15
1994 24
1995 21
1996 23
1997 32
1998 35
1999 29
2000 48
2001 34
2002 48
2003 34
2004 33
2005 43
2006 33
2007 31
2008 34
2009 40
2010 39
2011 31
2012 34
2013 47
2014 27
2015 47
2016 36
2017 40
2018 33
2019 41
2020 50
2021 39
Text availability
Article attribute
Article type
Publication date

Search Results

1,043 results
Results by year
Filters applied: . Clear all
Page 1
Management of post-transplant lymphoproliferative disorders.
DeStefano CB, Desai SH, Shenoy AG, Catlett JP. DeStefano CB, et al. Br J Haematol. 2018 Aug;182(3):330-343. doi: 10.1111/bjh.15263. Epub 2018 May 9. Br J Haematol. 2018. PMID: 29741774 Review.
The post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious complications of bone marrow and solid organ transplants. ...This paper will provide a comprehensive review of PTLD following sol …
The post-transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious com …
Post-transplant lymphoproliferative disorders.
Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Dharnidharka VR, et al. Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88. Nat Rev Dis Primers. 2016. PMID: 27189056 Review.
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the t …
PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Bar
Post-transplant lymphoproliferative disorders.
Singavi AK, Harrington AM, Fenske TS. Singavi AK, et al. Cancer Treat Res. 2015;165:305-27. doi: 10.1007/978-3-319-13150-4_13. Cancer Treat Res. 2015. PMID: 25655616 Review.
Post-transplant lymphoproliferative disorders (PTLD) are a serious complication after solid organ or allogeneic hematopoietic stem cell transplantation and include a range of diseases from benign proliferations to malignant lymphomas. Risk factors for …
Post-transplant lymphoproliferative disorders (PTLD) are a serious complication after solid organ or allogeneic hematopoietic …
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
Al-Mansour Z, Nelson BP, Evens AM. Al-Mansour Z, et al. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5. Curr Hematol Malig Rep. 2013. PMID: 23737188 Free PMC article. Review.
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. ...Clinically, extra-nodal di …
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferati …
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, Jakubowski A, Hanash AM, Kernan NA, Kobos R, Koehne G, Landau H, Ponce D, Spitzer B, Young JW, Behr G, Dunphy M, Haque S, Teruya-Feldstein J, Arcila M, Moung C, Hsu S, Hasan A, O'Reilly RJ. Prockop S, et al. J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127. J Clin Invest. 2020. PMID: 31689242 Free PMC article. Clinical Trial.
BACKGROUNDAdoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes (EBV-CTLs) can eradicate EBV-associated lymphomas (EBV-PTLD) after transplantation of hematopoietic cell (HCT) or solid organ (SOT) but is unavailable for most patients.METHODSW …
BACKGROUNDAdoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes (EBV-CTLs) can eradicate EBV-associated lymphomas ( …
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J. Romero S, et al. Leuk Lymphoma. 2019 Jan;60(1):142-150. doi: 10.1080/10428194.2018.1474462. Epub 2018 Jul 3. Leuk Lymphoma. 2019. PMID: 29966464
Post-transplant lymphoproliferative disorders (PTLD) are a rare complication after both solid organ (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT). ...In conclusion, the clinical presentation and the outcome of PTLD varies greatly de …
Post-transplant lymphoproliferative disorders (PTLD) are a rare complication after both solid organ (SOT) and allogeneic hemat …
Lymphoma: risk and response after solid organ transplant.
Jacobson CA, LaCasce AS. Jacobson CA, et al. Oncology (Williston Park). 2010 Sep;24(10):936-44. Oncology (Williston Park). 2010. PMID: 21138175 Free article. Review.
Post-transplant lymphoproliferative disorder (PTLD) is a common and serious complication of solid organ transplantation. ...Risk factors for the development of PTLD thus reflect loss or absence of EBV immunity; they include younger age and pre-transplant
Post-transplant lymphoproliferative disorder (PTLD) is a common and serious complication of solid organ transplantation
How I treat posttransplant lymphoproliferative disorders.
Dierickx D, Tousseyn T, Gheysens O. Dierickx D, et al. Blood. 2015 Nov 12;126(20):2274-83. doi: 10.1182/blood-2015-05-615872. Epub 2015 Sep 17. Blood. 2015. PMID: 26384356 Free article.
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disorder arising after solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). Iatrogenically impaired immune surveillance and Epstein-Barr virus (EBV) …
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disorder arising after solid organ transplant (SOT) …
Epstein-Barr virus-associated smooth muscle tumor in a kidney transplant recipient: A case-report and review of the literature.
Tardieu L, Meatchi T, Meyer L, Grataloup C, Bernard-Tessier A, Karras A, Thervet E, Lazareth H. Tardieu L, et al. Transpl Infect Dis. 2021 Feb;23(1):e13456. doi: 10.1111/tid.13456. Epub 2020 Sep 16. Transpl Infect Dis. 2021. PMID: 32881184
INTRODUCTION: Epstein-Barr virus (EBV) is a herpesvirus linked to pre-malignant lymphoproliferative diseases and up to nine distinct human tumors. ...CONCLUSION: PT-SMT is a rare but serious condition in kidney transplant recipients. EBV seroconversion follow …
INTRODUCTION: Epstein-Barr virus (EBV) is a herpesvirus linked to pre-malignant lymphoproliferative diseases and up to nine di …
Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P, Shiels MS, Lynch CF, Engels EA. Mahale P, et al. Am J Transplant. 2018 Feb;18(2):453-461. doi: 10.1111/ajt.14465. Epub 2017 Sep 2. Am J Transplant. 2018. PMID: 28805292 Free PMC article.
Using data from the US transplant registry linked with 17 cancer registries (1987-2014), we studied PCNSL and systemic non-Hodgkin lymphoma (NHL) in 288 029 solid organ transplant recipients. ...Compared to kidney recipients, PCNSL incidence was lower …
Using data from the US transplant registry linked with 17 cancer registries (1987-2014), we studied PCNSL and systemic non-Hodgkin …
1,043 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page